P390: ALLO-HSCT OR CHEMOTHERAPY FOR B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN THE FIRST COMPLETE REMISSION: IMPACT OF MRD AND IKZF1
Shiyu Deng,
Jiawang Ou,
Zihong Cai,
Zicong Huang,
Xiuli Xu,
Bingqing Tang
Affiliations
Shiyu Deng
1 Nanfang Hospital, Southern Medical University, Guangzhou, China, Guangdong Provincial Clinical Research Center for Hematologic Diseases, Department of Hematology, Guangzhou, China
Jiawang Ou
1 Nanfang Hospital, Southern Medical University, Guangzhou, China, Guangdong Provincial Clinical Research Center for Hematologic Diseases, Department of Hematology, Guangzhou, China
Zihong Cai
1 Nanfang Hospital, Southern Medical University, Guangzhou, China, Guangdong Provincial Clinical Research Center for Hematologic Diseases, Department of Hematology, Guangzhou, China
Zicong Huang
1 Nanfang Hospital, Southern Medical University, Guangzhou, China, Guangdong Provincial Clinical Research Center for Hematologic Diseases, Department of Hematology, Guangzhou, China
Xiuli Xu
1 Nanfang Hospital, Southern Medical University, Guangzhou, China, Guangdong Provincial Clinical Research Center for Hematologic Diseases, Department of Hematology, Guangzhou, China
Bingqing Tang
1 Nanfang Hospital, Southern Medical University, Guangzhou, China, Guangdong Provincial Clinical Research Center for Hematologic Diseases, Department of Hematology, Guangzhou, China
